100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Previously searched by you
Previously searched by you
logo
SOCRA CCRP Exam Questions and Answers 100% Solved $10.79
Add to cart
Quickly navigate to
Preview
  2.  
  3. SOCRA CCRP
  4.  
  5. SOCRA CCRP

Exam (elaborations)

SOCRA CCRP Exam Questions and Answers 100% Solved
 0 purchase
  • Course
  • SOCRA CCRP
  • Institution
  • SOCRA CCRP

Quality - ANSWER -ICH Q Efficacy - ANSWER -ICH E Safety - ANSWER -ICH S Multidisciplinary - ANSWER -ICH M guidance for industry, consolidated guideance - ANSWER -ICH E 6 Clinical Safety Data Management Definitions and Standards - ANSWER -ICH E2A Safety pharmacology studies for hum...

[Show more]

Preview 3 out of 17  pages

Document information

  • March 1, 2024
  • 17
  • 2023/2024
  • Exam (elaborations)
  • Questions & answers

Subjects

  • socra ccrp exam questions and answers 100 solved
  • socra ccrp exam questions and answers stuvia
  • april 30 1996 answer ich gcp development date

Written for

  • SOCRA CCRP
  • SOCRA CCRP

Seller

avatar-seller
IMORA

Reviews received

Content preview

SOCRA CCRP Exam Questions and
Answers 100% Solved
April 30 1996 - ANSWER -ICH GCP Development Date

Quality - ANSWER -ICH Q

Efficacy - ANSWER -ICH E

Safety - ANSWER -ICH S

Multidisciplinary - ANSWER -ICH M

guidance for industry, consolidated guideance - ANSWER -ICH E 6

Clinical Safety Data Management Definitions and Standards - ANSWER -ICH E2A

Safety pharmacology studies for human pharmaceuticals - ANSWER -ICH S7A

Electronic records, electronic signatures - ANSWER -21 CFR Part 11

Informed Consent - ANSWER -21 CFR Part 50

Financial Disclosures - ANSWER -21 CFR Part 54

Institutional Review Board - ANSWER -21 CFR Part 56

IND Application - ANSWER -21 CFR 312

New Drug Application - ANSWER -21 CFR 314

Investigational Device Exemption - ANSWER -21 CFR 812

21 CFR Part 814 - ANSWER -pre market approval of medical devices

45 CFR Part 46 - ANSWER -Federal Research

Studies that investigate the potential undesirable PD effects of a substance on
physiological functions in relation to exposure in the therapeutic range or above -
ANSWER -Safety Pharmacology Studies (Pre-Clinical)

1) To Identify undesirable PD properties of a substance that may have relevance to its
human safety.

,2) To evaluate adverse PD and/or pathophysio effects of a substance observed in
toxicology studies
3)to investigate the mechanism of the adverse PD effects observed and/or suspected -
ANSWER -Drug Development Safety Pharmacology Study Objectives (3)

1) Cardiovascular
2)Respiratory
3)CNS - ANSWER -Three vital organ considered highest priority

1) PK and toxicokinetic
2) Single dose toxicity
3) Repeated dose toxicity
4) Local tolerance
5) Genotoxicity
6) Carcinogenicity
7) Reproduction toxicity
8) Supplemental studies if needed - ANSWER -Types of Non-Clinical Studies (Animal
Trials)

Study that investigates the mode of action and/or effects of a drug substance in relation
to its desired therapeutic target - ANSWER -Primary Pharmacodynamic Studies

Studies that investigate the mode of action and/or effects of a drug substance not
related to its desire therapeutic target - ANSWER -Secondary Pharmacodynamic
Studies

Blood Pressure
Heart Rate
ECG/EKG
Repolarization/conductance abnormalities - ANSWER -Core Battery for Cardiovascular
System

Respiratory Rate
Functional Assessments (tidal volume, hgb Oxygen saturation) - ANSWER -Core
Battery for Respiratory System

Motor activity
behavioral changes
coordination
sensory/motor reflex response
temperature - ANSWER -Core Battery for Central Nervous System

Investigational New Drug Application
FDA - ANSWER -Before clinical trials can be initiated, an application containing the
appropriate information must be submitted to regulatory authorities, in the USA this is
called XXXX and submitted to the XXX (21 CFR Part 312)

, Unapproved drug to be shipped lawfully for the purpose of conducting investigations of
the drug - ANSWER -An IND permits what? (21 CFR Part 312)

Assuring the safety and rights of subjects - ANSWER -FDA's primary objective in all
phases of development is...

Phase II and III - ANSWER -These phase of trials, the FDA helps assure the quality of
the scientific evaluation is adequate to permit evaluation of the drugs safety and efficacy
(21 CFR Part 312)

The FDA - ANSWER -Who determines if Phase II/III studies are likely to yield data
capable of meeting regulatory standards for marketing approval?

1) Novelty of drug
2)Extent the drug has been studied previously
3) Known of suspected risks
4) Phase of development - ANSWER -IND information depends on the amount of
information available, these 4 things are: (21 CFR Part 312)

General Investigational Plan
Protocols for specific human studies - ANSWER -Initial IND should focus on (21 CFR
Part 312)

Build logically on previous submissions
Be supported by additional information such as animal studies and other human studies
- ANSWER -Amendments to IND with new or revised protocols (21 CFR Part 312)

Cover Sheet (FDA Form 1571)
Table of Contents
Introductory statement
investigator's brochure
protocol (s)
Chemistry and manufacturing information
pharm and tox information
previous human experience with investigational drug - ANSWER -A Sponsor Initiated
IND must contain (21 CFR Part 312)

30 Days, unless FDA notifies sponsor of clinical hold
Upon earlier notification, investigations may begin - ANSWER -How long does it take for
an IND to go into effect? (21 CFR Part 312)

1) To facilitate the availability of promising new drugs available to desperately ill patients
as early in the drug development process as possible, before general marketing begins
2)To obtain additional data on the drug's safety and effectiveness - ANSWER -The
purpose of Treatment Use of Investigational Drug (21 CFR Part 312)

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller IMORA. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $10.79. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

69252 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 15 years now

Start selling
$10.79
  • (0)
Add to cart
Added